Sleep disturbances in patients with amyotrophic lateral sclerosis: current perspectives

References

• Grad LI, Rouleau GA, Ravits J, Cashman NR. Clinical spectrum of amyotrophic lateral sclerosis (ALS). Cold Spring Harb Perspect Med. 2017;7:8. doi:10.1101/cshperspect.a024117
   Web of Science ®Google Scholar
• Hardiman O, Al-Chalabi A, Chio A, et al. Amyotrophic lateral sclerosis. Nat Rev Dis Primers. 2017;3:17071. doi:10.1038/nrdp.2017.7128980624
   PubMed Web of Science ®Google Scholar
• Mizutani T, Aki M, Shiozawa R, et al. Development of ophthalmoplegia in amyotrophic lateral sclerosis during long-term use of respirators. J Neurol Sci. 1990;99(2–3):311–319.2086731
   PubMed Web of Science ®Google Scholar
• Carvalho M, Schwartz MS, Swash M. Involvement of the external anal sphincter in amyotrophic lateral sclerosis. Muscle Nerve. 1995;18(8):848–853. doi:10.1002/mus.8801808087630345
   PubMed Web of Science ®Google Scholar
• Hortobagyi T, Cairns NJ. Amyotrophic lateral sclerosis and non-tau frontotemporal lobar degeneration. Handb Clin Neurol. 2017;145:369–381. doi:10.1016/B978-0-12-802395-2.00026-228987183
   PubMedGoogle Scholar
• Nakken O, Lindstrom JC, Tysnes OB, Holmoy T. Assessing amyotrophic lateral sclerosis prevalence in Norway from 2009 to 2015 from compulsory nationwide health registers. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19(3–4):303–310. doi:10.1080/21678421.2017.141800429271248
   PubMed Web of Science ®Google Scholar
• Kab S, Moisan F, Preux PM, Marin B, Elbaz A. Nationwide incidence of motor neuron disease using the French health insurance information system database. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18(5–6):426–433. doi:10.1080/21678421.2017.130656628387141
   PubMed Web of Science ®Google Scholar
• Rosenbohm A, Peter RS, Erhardt S, et al. Epidemiology of amyotrophic lateral sclerosis in Southern Germany. J Neurol. 2017;264(4):749–757. doi:10.1007/s00415-017-8413-328220290
   PubMed Web of Science ®Google Scholar
• Ragonese P, Cellura E, Aridon P, et al. Incidence of amyotrophic lateral sclerosis in Sicily: a population based study. Amyotroph Lateral Scler. 2012;13(3):284–287. doi:10.3109/17482968.2012.66268922409362
   PubMed Web of Science ®Google Scholar
• Chio A, Mora G, Calvo A, Mazzini L, Bottacchi E, Mutani R. Epidemiology of ALS in Italy: a 10-year prospective population-based study. Neurology. 2009;72(8):725–731. doi:10.1212/01.wnl.0000343008.26874.d119237701
   PubMed Web of Science ®Google Scholar
• Alonso A, Logroscino G, Jick SS, Hernan MA. Incidence and lifetime risk of motor neuron disease in the United Kingdom: a population-based study. Eur J Neurol. 2009;16(6):745–751.19475756
   PubMed Web of Science ®Google Scholar
• Foster LA, Salajegheh MK. Motor neuron disease: pathophysiology, diagnosis, and management. Am J Med. 2019;132(1):32–37. doi:10.1016/j.amjmed.2018.07.01230075105
   PubMed Web of Science ®Google Scholar
• Lacomblez L, Bensimon G, Leigh PN, et al. A confirmatory dose-ranging study of riluzole in ALS. ALS/Riluzole Study Group-II. Neurology. 1996;47(6 Suppl 4):S242–S250. doi:10.1212/wnl.47.6_suppl_4.242s8959996
   PubMed Web of Science ®Google Scholar
• Lacomblez L, Bensimon G, Leigh PN, Guillet P, Meininger V. Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Lancet. 1996;347(9013):1425–1431. doi:10.1016/s0140-6736(96)91680-38676624
   PubMed Web of Science ®Google Scholar
• Bensimon G, Lacomblez L, Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N Engl J Med. 1994;330(9):585–591. doi:10.1056/NEJM1994030333009018302340
   PubMed Web of Science ®Google Scholar
• Writing Group On Behalf Of The Edaravone Als 18 Study G. Exploratory double-blind, parallel-group, placebo-controlled study of edaravone (MCI-186) in amyotrophic lateral sclerosis (Japan ALS severity classification: grade 3, requiring assistance for eating, excretion or ambulation). Amyotroph Lateral Scler Frontotemporal Degener. 2017;18(sup1):40–48. doi:10.1080/21678421.2017.136144128872915
   PubMed Web of Science ®Google Scholar
• Takei K, Takahashi F, Liu S, Tsuda K, Palumbo J. Post-hoc analysis of randomised, placebo-controlled, double-blind study (MCI186-19) of edaravone (MCI-186) in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18(sup1):49–54. doi:10.1080/21678421.2017.136144328872913
   PubMed Web of Science ®Google Scholar
• Andersen PM, Abrahams S, Borasio GD, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)–revised report of an EFNS task force. Eur J Neurol. 2012;19(3):360–375. doi:10.1111/j.1468-1331.2011.03501.x21914052
   PubMed Web of Science ®Google Scholar
• Traxinger K, Kelly C, Johnson BA, Lyles RH, Glass JD. Prognosis and epidemiology of amyotrophic lateral sclerosis: analysis of a clinic population, 1997–2011. Neurol Clin Pract. 2013;3(4):313–320. doi:10.1212/CPJ.0b013e3182a1b8ab24195020
   PubMedGoogle Scholar
• Zoccolella S, Beghi E, Palagano G, et al. Analysis of survival and prognostic factors in amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry. 2008;79(1):33–37. doi:10.1136/jnnp.2007.11801817550991
   PubMed Web of Science ®Google Scholar
• Calvo A, Moglia C, Lunetta C, et al. Factors predicting survival in ALS: a multicenter Italian study. J Neurol. 2017;264(1):54–63. doi:10.1007/s00415-016-8313-y27778156
   PubMed Web of Science ®Google Scholar
• Piepers S, van Den Berg JP, Kalmijn S, et al. Effect of non-invasive ventilation on survival, quality of life, respiratory function and cognition: a review of the literature. Amyotroph Lateral Scler. 2006;7(4):195–200. doi:10.1080/1466082050051497417127557
   PubMed Web of Science ®Google Scholar
• Kleopa KA, Sherman M, Neal B, Romano GJ, Heiman-Patterson T. Bipap improves survival and rate of pulmonary function decline in patients with ALS. J Neurol Sci. 1999;164(1):82–88.10385053
   PubMed Web of Science ®Google Scholar
• Spataro R, Re M L, Piccoli T, Piccoli F, La Bella V. Causes and place of death in Italian patients with amyotrophic lateral sclerosis. Acta Neurol Scand. 2010;122(3):217–223. doi:10.1111/j.1600-0404.2009.01290.x20078446
   PubMed Web of Science ®Google Scholar
• Gil J, Funalot B, Verschueren A, et al. Causes of death amongst French patients with amyotrophic lateral sclerosis: a prospective study. Eur J Neurol. 2008;15(11):1245–1251. doi:10.1111/j.1468-1331.2008.02307.x18973614
   PubMed Web of Science ®Google Scholar
• Oliveira AS, Pereira RD. Amyotrophic lateral sclerosis (ALS): three letters that change the people’s life. For Ever Arq Neuropsiquiatr. 2009;67(3A):750–782. doi:10.1590/S0004-282X200900040004019722069
   PubMed Web of Science ®Google Scholar
• Motor Neuron Disease Association, 2009 Available from: https://www.youtube.com/watch?v=4b-h_XBArC4. Accessed March 15, 2019.
   Google Scholar
• Bourke SC, McColl E, Shaw PJ, Gibson GJ. Validation of quality of life instruments in ALS. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004;5(1):55–60. doi:10.1080/14660820310016066
   PubMed Web of Science ®Google Scholar
• Bromberg MB. Quality of life in amyotrophic lateral sclerosis. Phys Med Rehabil Clin N Am. 2008;19(3):591–605, x-xi. doi:10.1016/j.pmr.2008.02.005
   Web of Science ®Google Scholar
• Epton J, Harris R, Jenkinson C. Quality of life in amyotrophic lateral sclerosis/motor neuron disease: a structured review. Amyotroph Lateral Scler. 2009;10(1):15–26. doi:10.1080/1748296080216372118752087
   PubMed Web of Science ®Google Scholar
• Burke T, Galvin M, Pinto-Grau M, et al. Caregivers of patients with amyotrophic lateral sclerosis: investigating quality of life, caregiver burden, service engagement, and patient survival. J Neurol. 2017;264(5):898–904. doi:10.1007/s00415-017-8448-528280986
   PubMed Web of Science ®Google Scholar
• Raheja D, Stephens HE, Lehman E, Walsh S, Yang C, Simmons Z. Patient-reported problematic symptoms in an ALS treatment trial. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17(3–4):198–205. doi:10.3109/21678421.2015.113183126824413
   PubMed Web of Science ®Google Scholar
• Panda S, Gourie-Devi M, Sharma A. Sleep disorders in amyotrophic lateral sclerosis: a questionnaire-based study from India. Neurol India. 2018;66(3):700–708. doi:10.4103/0028-3886.23232729766929
   PubMed Web of Science ®Google Scholar
• Lo Coco D, La Bella V. Fatigue, sleep, and nocturnal complaints in patients with amyotrophic lateral sclerosis. Eur J Neurol. 2012;19(5):760–763. doi:10.1111/j.1468-1331.2011.03637.x22233269
   PubMed Web of Science ®Google Scholar
• Lo Coco D, Mattaliano P, Spataro R, Mattaliano A, La Bella V. Sleep-wake disturbances in patients with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2011;82(8):839–842. doi:10.1136/jnnp.2010.22800721217159
   PubMed Web of Science ®Google Scholar
• Diaz-Abad M, Buczyner JR, Venza BR, et al. Poor sleep quality in patients with amyotrophic lateral sclerosis at the time of diagnosis. J Clin Neuromuscul Dis. 2018;20(2):60–68. doi:10.1097/CND.000000000000023430439751
   PubMedGoogle Scholar
• Ahmed RM, Newcombe RE, Piper AJ, et al. Sleep disorders and respiratory function in amyotrophic lateral sclerosis. Sleep Med Rev. 2016;26:33–42. doi:10.1016/j.smrv.2015.05.00726166297
   PubMed Web of Science ®Google Scholar
• American Academy of Sleep Medicine. International Classification of Sleep Disorders, 3rd edition (ICSD-3). Westchester, IL. American Academy of Sleep Medicine; 2014.
   Google Scholar
• Ferguson KA, Strong MJ, Ahmad D, George CF. Sleep-disordered breathing in amyotrophic lateral sclerosis. Chest. 1996;110(3):664–669. doi:10.1378/chest.110.3.6648797409
   PubMed Web of Science ®Google Scholar
• Santos C, Braghiroli A, Mazzini L, Pratesi R, Oliveira LV, Mora G. Sleep-related breathing disorders in amyotrophic lateral sclerosis. Monaldi Arch Chest Dis. 2003;59(2):160–165.14635507
   PubMedGoogle Scholar
• Boentert M, Glatz C, Helmle C, Okegwo A, Young P. Prevalence of sleep apnoea and capnographic detection of nocturnal hypoventilation in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2018;89(4):418–424. doi:10.1136/jnnp-2017-31651529054915
   PubMed Web of Science ®Google Scholar
• Quaranta VN, Carratu P, Damiani MF, et al. The prognostic role of obstructive sleep apnea at the onset of amyotrophic lateral sclerosis. Neurodegener Dis. 2017;17(1):14–21. doi:10.1159/00044756027595268
   PubMed Web of Science ®Google Scholar
• Lyall RA, Donaldson N, Polkey MI, Leigh PN, Moxham J. Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis. Brain. 2001;124(Pt 10):2000–2013. doi:10.1093/brain/124.10.200011571218
   PubMed Web of Science ®Google Scholar
• Berger KIRDM, Ayappa I, Goldring RM. Pathophysiology of hypoventilation during sleep. Sleep Med Clin. 2014;9:289–300. doi:10.1016/j.jsmc.2014.05.014
   Google Scholar
• Ogna A, Quera Salva MA, Prigent H, et al. Nocturnal hypoventilation in neuromuscular disease: prevalence according to different definitions issued from the literature. Sleep Breath. 2016;20(2):575–581. doi:10.1007/s11325-015-1247-226338464
   PubMed Web of Science ®Google Scholar
• Berry RBBR, Gamaldo CE, Harding SM, Lloyd RM, Marcus CL, Vaughn BV; for the American Academy of Sleep Medicine. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications, Version 2.2. Darien, Illinois: American Academy of Sleep Medicine; 2015 Available from: http://www.aasmnet.org. Accessed 717, 2019.
   Google Scholar
• Boentert M, Brenscheidt I, Glatz C, Young P. Effects of non-invasive ventilation on objective sleep and nocturnal respiration in patients with amyotrophic lateral sclerosis. J Neurol. 2015;262(9):2073–2082. doi:10.1007/s00415-015-7822-426076745
   PubMed Web of Science ®Google Scholar
• Katzberg HD, Selegiman A, Guion L, et al. Effects of noninvasive ventilation on sleep outcomes in amyotrophic lateral sclerosis. J Clin Sleep Med. 2013;9(4):345–351. doi:10.5664/jcsm.258623585750
   PubMed Web of Science ®Google Scholar
• Vrijsen B, Buyse B, Belge C, et al. Noninvasive ventilation improves sleep in amyotrophic lateral sclerosis: a prospective polysomnographic study. J Clin Sleep Med. 2015;11(5):559–566. doi:10.5664/jcsm.470425766713
   PubMed Web of Science ®Google Scholar
• David WS, Bundlie SR, Mahdavi Z. Polysomnographic studies in amyotrophic lateral sclerosis. J Neurol Sci. 1997;152(Suppl 1):S29–S35.9419051
   PubMed Web of Science ®Google Scholar
• Arnulf I, Similowski T, Salachas F, et al. Sleep disorders and diaphragmatic function in patients with amyotrophic lateral sclerosis. Am J Respir Crit Care Med. 2000;161(3 Pt 1):849–856. doi:10.1164/ajrccm.161.3.980500810712332
   PubMed Web of Science ®Google Scholar
• Atalaia A, De Carvalho M, Evangelista T, Pinto A. Sleep characteristics of amyotrophic lateral sclerosis in patients with preserved diaphragmatic function. Amyotroph Lateral Scler. 2007;8(2):101–105. doi:10.1080/1748296060102988317453638
   PubMed Web of Science ®Google Scholar
• Just N, Bautin N, Danel-Brunaud V, Debroucker V, Matran R, Perez T. The Borg dyspnoea score: a relevant clinical marker of inspiratory muscle weakness in amyotrophic lateral sclerosis. Eur Respir J. 2010;35(2):353–360. doi:10.1183/09031936.0018490819741023
   PubMed Web of Science ®Google Scholar
• Fitting JW, Paillex R, Hirt L, Aebischer P, Schluep M. Sniff nasal pressure: a sensitive respiratory test to assess progression of amyotrophic lateral sclerosis. Ann Neurol. 1999;46(6):887–893.10589541
   PubMed Web of Science ®Google Scholar
• Morgan RK, McNally S, Alexander M, Conroy R, Hardiman O, Costello RW. Use of Sniff nasal-inspiratory force to predict survival in amyotrophic lateral sclerosis. Am J Respir Crit Care Med. 2005;171(3):269–274. doi:10.1164/rccm.200403-314OC15516537
   PubMed Web of Science ®Google Scholar
• Czaplinski A, Yen AA, Appel SH. Forced vital capacity (FVC) as an indicator of survival and disease progression in an ALS clinic population. J Neurol Neurosurg Psychiatry. 2006;77(3):390–392. doi:10.1136/jnnp.2005.07266016484652
   PubMed Web of Science ®Google Scholar
• Tilanus TBM, Groothuis JT, TenBroek-Pastoor JMC, et al. The predictive value of respiratory function tests for non-invasive ventilation in amyotrophic lateral sclerosis. Respir Res. 2017;18(1):144. doi:10.1186/s12931-017-0624-828743265
   PubMed Web of Science ®Google Scholar
• Carratu P, Cassano A, Gadaleta F, et al. Association between low sniff nasal-inspiratory pressure (SNIP) and sleep disordered breathing in amyotrophic lateral sclerosis: preliminary results. Amyotroph Lateral Scler. 2011;12(6):458–463. doi:10.3109/17482968.2011.59303821745123
   PubMed Web of Science ®Google Scholar
• AAHCP/AARC/AACP/AAP/ASDA/ATS/NAMDRC. Clinical indications for noninvasive positive pressure ventilation in chronic respiratory failure due to restrictive lung disease, COPD, and nocturnal hypoventilation – a consensus conference report. Chest. 1999;116(521–534):521-534.
   Google Scholar
• American Thoracic Society/European Respiratory Society. ATS/ERS statement on respiratory muscle testing. Am J Respir Crit Care Med. 2002;166(4):518–624. doi:10.1164/rccm.166.4.51812186831
   PubMed Web of Science ®Google Scholar
• de Carvalho M, Matias T, Coelho F, Evangelista T, Pinto A, Luis ML. Motor neuron disease presenting with respiratory failure. J Neurol Sci. 1996;139:Suppl:117–122. doi:10.1016/0022-510X(96)00089-5
   Web of Science ®Google Scholar
• Gautier G, Verschueren A, Monnier A, Attarian S, Salort-Campana E, Pouget J. ALS with respiratory onset: clinical features and effects of non-invasive ventilation on the prognosis. Amyotroph Lateral Scler. 2010;11(4):379–382. doi:10.3109/1748296090342654320001486
   PubMed Web of Science ®Google Scholar
• Barthlen GM, Lange DJ. Unexpectedly severe sleep and respiratory pathology in patients with amyotrophic lateral sclerosis. Eur J Neurol. 2000;7(3):299–302.10886313
   PubMed Web of Science ®Google Scholar
• Aboussouan LS, Khan SU, Banerjee M, Arroliga AC, Mitsumoto H. Objective measures of the efficacy of noninvasive positive-pressure ventilation in amyotrophic lateral sclerosis. Muscle Nerve. 2001;24(3):403–409.11353427
   PubMed Web of Science ®Google Scholar
• Aboussouan LS, Khan SU, Meeker DP, Stelmach K, Mitsumoto H. Effect of noninvasive positive-pressure ventilation on survival in amyotrophic lateral sclerosis. Ann Intern Med. 1997;127(6):450–453. doi:10.7326/0003-4819-127-6-199709150-000069313002
   PubMed Web of Science ®Google Scholar
• Bach JR. Amyotrophic lateral sclerosis: predictors for prolongation of life by noninvasive respiratory aids. Arch Phys Med Rehabil. 1995;76(9):828–832.7668953
   PubMed Web of Science ®Google Scholar
• Bach JR. Amyotrophic lateral sclerosis: prolongation of life by noninvasive respiratory AIDS. Chest. 2002;122(1):92–98. doi:10.1378/chest.122.1.9212114343
   PubMed Web of Science ®Google Scholar
• Bertella E, Banfi P, Paneroni M, et al. Early initiation of night-time NIV in an outpatient setting: a randomized non-inferiority study in ALS patients. Eur J Phys Rehabil Med. 2017;53(6):892–899. doi:10.23736/S1973-9087.17.04511-728382811
   PubMed Web of Science ®Google Scholar
• Bourke SC, Tomlinson M, Williams TL, Bullock RE, Shaw PJ, Gibson GJ. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. Lancet Neurol. 2006;5(2):140–147. doi:10.1016/S1474-4422(05)70326-416426990
   PubMed Web of Science ®Google Scholar
• Burkhardt C, Neuwirth C, Sommacal A, Andersen PM, Weber M. Is survival improved by the use of NIV and PEG in amyotrophic lateral sclerosis (ALS)? A post-mortem study of 80 ALS patients. PLoS One. 2017;12(5):e0177555. doi:10.1371/journal.pone.017755528542233
   PubMed Web of Science ®Google Scholar
• Butz M, Wollinsky KH, Wiedemuth-Catrinescu U, et al. Longitudinal effects of noninvasive positive-pressure ventilation in patients with amyotrophic lateral sclerosis. Am J Phys Med Rehabil. 2003;82(8):597–604. doi:10.1097/01.PHM.0000078239.83545.D012872016
   PubMed Web of Science ®Google Scholar
• Chio A, Calvo A, Moglia C, et al. Non-invasive ventilation in amyotrophic lateral sclerosis: a 10 year population based study. J Neurol Neurosurg Psychiatry. 2012;83(4):377–381. doi:10.1136/jnnp-2011-30047222013242
   PubMed Web of Science ®Google Scholar
• Elamin EM, Wilson CS, Sriaroon C, et al. Effects of early introduction of non-invasive positive pressure ventilation based on forced vital capacity rate of change: variation across amyotrophic lateral sclerosis clinical phenotypes. Int J Clin Pract. 2019;73(1):e13257. doi:10.1111/ijcp.1325730230161
   PubMed Web of Science ®Google Scholar
• Pinto AC, Evangelista T, Carvalho M, Alves MA, Sales Luis ML. Respiratory assistance with a non-invasive ventilator (Bipap) in MND/ALS patients: survival rates in a controlled trial. J Neurol Sci. 1995;129:Suppl:19–26. doi:10.1016/0022-510X(95)00052-4
   Web of Science ®Google Scholar
• Sivori M, Rodriguez GE, Pascansky D, Saenz C, Sica RE. Outcome of sporadic amyotrophic lateral sclerosis treated with non-invasive ventilation and riluzole. Medicina (B Aires). 2007;67(4):326–330.17891927
   PubMed Web of Science ®Google Scholar
• Vitacca M, Montini A, Lunetta C, et al. Impact of an early respiratory care programme with non-invasive ventilation adaptation in patients with amyotrophic lateral sclerosis. Eur J Neurol. 2018;25(3):556–e533. doi:10.1111/ene.1354729266547
   PubMed Web of Science ®Google Scholar
• Storre JH, Magnet FS, Dreher M, Windisch W. Transcutaneous monitoring as a replacement for arterial PCO(2) monitoring during nocturnal non-invasive ventilation. Respir Med. 2011;105(1):143–150. doi:10.1016/j.rmed.2010.10.00721030230
   PubMed Web of Science ®Google Scholar
• Georges M, Nguyen-Baranoff D, Griffon L, et al. Usefulness of transcutaneous PCO2 to assess nocturnal hypoventilation in restrictive lung disorders. Respirology. 2016;21(7):1300–1306. doi:10.1111/resp.1281227185178
   PubMed Web of Science ®Google Scholar
• Kushida CA, Littner MR, Morgenthaler T, et al. Practice parameters for the indications for polysomnography and related procedures: an update for 2005. Sleep. 2005;28(4):499–521. doi:10.1093/sleep/28.4.49916171294
   PubMed Web of Science ®Google Scholar
• Rod NH, Kumari M, Lange T, Kivimaki M, Shipley M, Ferrie J. The joint effect of sleep duration and disturbed sleep on cause-specific mortality: results from the Whitehall II cohort study. PLoS One. 2014;9(4):e91965. doi:10.1371/journal.pone.009196524699341
   PubMed Web of Science ®Google Scholar
• Congiu PT, Milioli G, Borghero G, Puligheddu M. Sleep, sleep structure and sleep disorders in a cohort of patients affected by ALS. Ann Community Med Pract. 2018;4(1):1028.
   Google Scholar
• Vandoorne E, Vrijsen B, Belge C, Testelmans D, Buyse B. Noninvasive ventilation in amyotrophic lateral sclerosis: effects on sleep quality and quality of life. Acta Clin Belg. 2016;71(6):389–394. doi:10.1080/17843286.2016.117394127112318
   PubMed Web of Science ®Google Scholar
• Mustfa N, Walsh E, Bryant V, et al. The effect of noninvasive ventilation on ALS patients and their caregivers. Neurology. 2006;66(8):1211–1217. doi:10.1212/01.wnl.0000208957.88534.1116636239
   PubMed Web of Science ®Google Scholar
• Lyall RA, Donaldson N, Fleming T, et al. A prospective study of quality of life in ALS patients treated with noninvasive ventilation. Neurology. 2001;57(1):153–156. doi:10.1212/wnl.57.1.15311445650
   PubMed Web of Science ®Google Scholar
• Teschler H, Stampa J, Ragette R, Konietzko N, Berthon-Jones M. Effect of mouth leak on effectiveness of nasal bilevel ventilatory assistance and sleep architecture. Eur Respir J. 1999;14(6):1251–1257.10624751
   PubMed Web of Science ®Google Scholar
• Schellhas V, Glatz C, Beecken I, et al. Upper airway obstruction induced by non-invasive ventilation using an oronasal interface. Sleep Breath. 2018;22(3):781–788. doi:10.1007/s11325-018-1640-829453639
   PubMed Web of Science ®Google Scholar
• Crescimanno G, Greco F, Arrisicato S, Morana N, Marrone O. Effects of positive end expiratory pressure administration during non-invasive ventilation in patients affected by amyotrophic lateral sclerosis: a randomized crossover study. Respirology. 2016;21(7):1307–1313. doi:10.1111/resp.1283627323697
   PubMed Web of Science ®Google Scholar
• Atkeson AD, RoyChoudhury A, Harrington-Moroney G, Shah B, Mitsumoto H, Basner RC. Patient-ventilator asynchrony with nocturnal noninvasive ventilation in ALS. Neurology. 2011;77(6):549–555. doi:10.1212/WNL.0b013e318228c0fb21795658
   PubMed Web of Science ®Google Scholar
• Sancho J, Servera E, Morelot-Panzini C, Salachas F, Similowski T, Gonzalez-Bermejo J. Non-invasive ventilation effectiveness and the effect of ventilatory mode on survival in ALS patients. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15(1–2):55–61. doi:10.3109/21678421.2013.85579024266679
   PubMed Web of Science ®Google Scholar
• Georges M, Attali V, Golmard JL, et al. Reduced survival in patients with ALS with upper airway obstructive events on non-invasive ventilation. J Neurol Neurosurg Psychiatry. 2016;87(10):1045–1050. doi:10.1136/jnnp-2015-31260627090433
   PubMed Web of Science ®Google Scholar
• Gonzalez-Bermejo J, Morelot-Panzini C, Arnol N, et al. Prognostic value of efficiently correcting nocturnal desaturations after one month of non-invasive ventilation in amyotrophic lateral sclerosis: a retrospective monocentre observational cohort study. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14(5–6):373–379. doi:10.3109/21678421.2013.77608623527531
   PubMed Web of Science ®Google Scholar
• Ogna A, Nardi J, Prigent H, et al. Prognostic value of initial assessment of residual hypoventilation using nocturnal capnography in mechanically ventilated neuromuscular patients: a 5-year follow-up study. Front Med (Lausanne). 2016;3:40.27679799
   PubMed Web of Science ®Google Scholar
• Volanti P, Cibella F, Sarva M, et al. Predictors of non-invasive ventilation tolerance in amyotrophic lateral sclerosis. J Neurol Sci. 2011;303(1–2):114–118. doi:10.1016/j.jns.2010.12.02121276597
   PubMed Web of Science ®Google Scholar
• Sancho J, Martinez D, Bures E, Diaz JL, Ponz A, Servera E. Bulbar impairment score and survival of stable amyotrophic lateral sclerosis patients after noninvasive ventilation initiation. ERJ Open Res. 2018;4:2. doi:10.1183/23120541.00159-2017
   Google Scholar
• Bortolotti M. Laryngospasm and reflex central apnoea caused by aspiration of refluxed gastric content in adults. Gut. 1989;30(2):233–238. doi:10.1136/gut.30.2.2332703145
   PubMed Web of Science ®Google Scholar
• Kuhnlein P, Gdynia HJ, Sperfeld AD, et al. Diagnosis and treatment of bulbar symptoms in amyotrophic lateral sclerosis. Nat Clin Pract Neurol. 2008;4(7):366–374. doi:10.1038/ncpneuro085318560390
   PubMedGoogle Scholar
• Montagna P, Liguori R, Zucconi M, Lugaresi A, Cirignotta F, Lugaresi E. Fasciculations during wakefulness and sleep. Acta Neurol Scand. 1987;76(2):152–154.3673501
   PubMed Web of Science ®Google Scholar
• Stephens HE, Joyce NC, Oskarsson B. National study of muscle cramps in ALS in the USA. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18(1–2):32–36. doi:10.1080/21678421.2016.1245755
   PubMed Web of Science ®Google Scholar
• Caress JB, Ciarlone SL, Sullivan EA, Griffin LP, Cartwright MS. Natural history of muscle cramps in amyotrophic lateral sclerosis. Muscle Nerve. 2016;53(4):513–517. doi:10.1002/mus.2489226332705
   PubMed Web of Science ®Google Scholar
• Baldissera F, Cavallari P, Dworzak F. Motor neuron ‘bistability’. A pathogenetic mechanism for cramps and myokymia. Brain. 1994;117(Pt 5):929–939. doi:10.1093/brain/117.5.9297953602
   PubMed Web of Science ®Google Scholar
• Hallegraeff JM, van der Schans CP, de Ruiter R, de Greef MH. Stretching before sleep reduces the frequency and severity of nocturnal leg cramps in older adults: a randomised trial. J Physiother. 2012;58(1):17–22. doi:10.1016/S1836-9553(12)70068-122341378
   PubMed Web of Science ®Google Scholar
• Oskarsson B, Moore D, Mozaffar T, et al. Mexiletine for muscle cramps in amyotrophic lateral sclerosis: a randomized, double-blind crossover trial. Muscle Nerve. 2018. doi:10.1002/mus.26117
   Web of Science ®Google Scholar
• Baldinger R, Katzberg HD, Weber M. Treatment for cramps in amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev. 2012;(4):CD004157. doi: 10.1002/14651858. 22513921
   PubMed Web of Science ®Google Scholar
• El-Tawil S, Al Musa T, Valli H, et al. Quinine for muscle cramps. Cochrane Database Syst Rev. 2015;(4):CD005044. doi: 10.1002/14651858.CD005044.pub325842375
   PubMed Web of Science ®Google Scholar
• Hogan DB. Quinine: not a safe drug for treating nocturnal leg cramps. CMAJ. 2015;187(4):237–238. doi:10.1503/cmaj.15004425623647
   PubMed Web of Science ®Google Scholar
• Skarpsno ES, Mork PJ, Nilsen TIL, Holtermann A. Sleep positions and nocturnal body movements based on free-living accelerometer recordings: association with demographics, lifestyle, and insomnia symptoms. Nat Sci Sleep. 2017;9:267–275. doi:10.2147/NSS.S14577729138608
   PubMed Web of Science ®Google Scholar
• Chen JH, Wu SC, Chen HJ, Kao CH, Tseng CH, Tsai CH. Risk of developing pressure sore in amyotrophic lateral sclerosis patients - a nationwide cohort study. J Eur Acad Dermatol Venereol. 2018;32(9):1589–1596. doi:10.1111/jdv.1491129512203
   PubMed Web of Science ®Google Scholar
• Hayashi T, Narita Y, Okugawa N, Hamaguchi E, Shibahara M, Kuzuhara S. Pressure ulcers in ALS patients on admission at a university hospital in Japan. Amyotroph Lateral Scler. 2007;8(5):310–313. doi:10.1080/1748296070153882517852025
   PubMed Web of Science ®Google Scholar
• Ono S, Toyokura Y, Mannen T, Ishibashi Y. Increased dermal collagen density in amyotrophic lateral sclerosis. J Neurol Sci. 1988;83(1):81–92.3346711
   PubMed Web of Science ®Google Scholar
• Finan PH, Goodin BR, Smith MT. The association of sleep and pain: an update and a path forward. J Pain. 2013;14(12):1539–1552. doi:10.1016/j.jpain.2013.08.00724290442
   PubMed Web of Science ®Google Scholar
• Cheatle MD, Foster S, Pinkett A, Lesneski M, Qu D, Dhingra L. Assessing and managing sleep disturbance in patients with chronic pain. Sleep Med Clin. 2016;11(4):531–541. doi:10.1016/j.jsmc.2016.08.00428118876
   PubMedGoogle Scholar
• Moisset X, Cornut-Chauvinc C, Clavelou P, Pereira B, Dallel R, Guy N. Is there pain with neuropathic characteristics in patients with amyotrophic lateral sclerosis? A cross-sectional study. Palliat Med. 2016;30(5):486–494. doi:10.1177/026921631560033226269326
   PubMed Web of Science ®Google Scholar
• Wallace VC, Ellis CM, Burman R, Knights C, Shaw CE, Al-Chalabi A. The evaluation of pain in amyotrophic lateral sclerosis: a case controlled observational study. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15(7–8):520–527. doi:10.3109/21678421.2014.95194425204842
   PubMed Web of Science ®Google Scholar
• Dalla Bella E, Lombardi R, Porretta-Serapiglia C, et al. Amyotrophic lateral sclerosis causes small fiber pathology. Eur J Neurol. 2016;23(2):416–420. doi:10.1111/ene.1293626806218
   PubMed Web of Science ®Google Scholar
• Nijs J, Torres-Cueco R, van Wilgen CP, et al. Applying modern pain neuroscience in clinical practice: criteria for the classification of central sensitization pain. Pain Physician. 2014;17(5):447–457.25247901
   PubMed Web of Science ®Google Scholar
• Ziegler EA, Magerl W, Meyer RA, Treede RD. Secondary hyperalgesia to punctate mechanical stimuli. Central sensitization to A-fibre nociceptor input. Brain. 1999;122(Pt 12):2245–2257. doi:10.1093/brain/122.12.224510581220
   PubMed Web of Science ®Google Scholar
• Chio A, Mora G, Lauria G. Pain in amyotrophic lateral sclerosis. Lancet Neurol. 2017;16(2):144–157. doi:10.1016/S1474-4422(16)30358-127964824
   PubMed Web of Science ®Google Scholar
• Ganzini L, Silveira MJ, Johnston WS. Predictors and correlates of interest in assisted suicide in the final month of life among ALS patients in Oregon and Washington. J Pain Symptom Manage. 2002;24(3):312–317.12458112
   PubMed Web of Science ®Google Scholar
• Hogl B, Kiechl S, Willeit J, et al. Restless legs syndrome: a community-based study of prevalence, severity, and risk factors. Neurology. 2005;64(11):1920–1924. doi:10.1212/01.WNL.0000163996.64461.A315955944
   PubMed Web of Science ®Google Scholar
• Abetz L, Allen R, Follet A, et al. Evaluating the quality of life of patients with restless legs syndrome. Clin Ther. 2004;26(6):925–935.15262463
   PubMed Web of Science ®Google Scholar
• Limousin N, Blasco H, Corcia P, Arnulf I, Praline J. The high frequency of restless legs syndrome in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2011;12(4):303–306. doi:10.3109/17482968.2011.55773621314298
   PubMed Web of Science ®Google Scholar
• Liu S, Shen D, Tai H, et al. Restless legs syndrome in Chinese patients with sporadic amyotrophic lateral sclerosis. Front Neurol. 2018;9:735. doi:10.3389/fneur.2018.0073530214425
   PubMed Web of Science ®Google Scholar
• Lo Coco D, Piccoli F, La Bella V. Restless legs syndrome in patients with amyotrophic lateral sclerosis. Mov Disord. 2010;25(15):2658–2661. doi:10.1002/mds.2326120669314
   PubMed Web of Science ®Google Scholar
• Weis J, Katona I, Muller-Newen G, et al. Small-fiber neuropathy in patients with ALS. Neurology. 2011;76(23):2024–2029. doi:10.1212/WNL.0b013e31821e553a21646630
   PubMed Web of Science ®Google Scholar
• Isak B, Tankisi H, Johnsen B, et al. Involvement of distal sensory nerves in amyotrophic lateral sclerosis. Muscle Nerve. 2016;54(6):1086–1092. doi:10.1002/mus.2515727104485
   PubMed Web of Science ®Google Scholar
• Wijemanne S, Ondo W. Restless legs syndrome: clinical features, diagnosis and a practical approach to management. Pract Neurol. 2017;17(6):444–452. doi:10.1136/practneurol-2017-00176229097554
   PubMedGoogle Scholar
• Garcia-Borreguero D, Silber MH, Winkelman JW, et al. Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation. Sleep Med. 2016;21:1–11. doi:10.1016/j.sleep.2016.01.01727448465
   PubMed Web of Science ®Google Scholar
• Puligheddu M, Congiu P, Arico D, et al. Isolated rapid eye movement sleep without atonia in amyotrophic lateral sclerosis. Sleep Med. 2016;26:16–22. doi:10.1016/j.sleep.2016.05.01628007355
   PubMed Web of Science ®Google Scholar
• Lo Coco D, Puligheddu M, Mattaliano P, et al. REM sleep behavior disorder and periodic leg movements during sleep in ALS. Acta Neurol Scand. 2017;135(2):219–224. doi:10.1111/ane.1259327027974
   PubMed Web of Science ®Google Scholar
• Moszczynski AJ, Tandon A, Coelho FM, Zinman L, Murray B. Mortality associated with periodic limb movements during sleep in amyotrophic lateral sclerosis patients. Einstein (Sao Paulo). 2012;10(4):428–432.23386081
   PubMedGoogle Scholar
• Cedarbaum JM, Stambler N, Malta E, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci. 1999;169(1–2):13–21.10540002
   PubMed Web of Science ®Google Scholar
• Bara-Jimenez W, Aksu M, Graham B, Sato S, Hallett M. Periodic limb movements in sleep: state-dependent excitability of the spinal flexor reflex. Neurology. 2000;54(8):1609–1616. doi:10.1212/wnl.54.8.160910762502
   PubMed Web of Science ®Google Scholar
• Luppi PH, Clement O, Sapin E, et al. The neuronal network responsible for paradoxical sleep and its dysfunctions causing narcolepsy and rapid eye movement (REM) behavior disorder. Sleep Med Rev. 2011;15(3):153–163. doi:10.1016/j.smrv.2010.08.00221115377
   PubMed Web of Science ®Google Scholar
• Hogl B, Stefani A, Videnovic A. Idiopathic REM sleep behaviour disorder and neurodegeneration - an update. Nat Rev Neurol. 2018;14(1):40–55. doi:10.1038/nrneurol.2017.15729170501
   PubMed Web of Science ®Google Scholar
• Iranzo A, Fernandez-Arcos A, Tolosa E, et al. Neurodegenerative disorder risk in idiopathic REM sleep behavior disorder: study in 174 patients. PLoS One. 2014;9(2):e89741. doi:10.1371/journal.pone.008974124587002
   PubMed Web of Science ®Google Scholar
• Boeve BF, Silber MH, Ferman TJ, et al. Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder. Sleep Med. 2013;14(8):754–762. doi:10.1016/j.sleep.2012.10.01523474058
   PubMed Web of Science ®Google Scholar
• Sabater L, Gaig C, Gelpi E, et al. A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study. Lancet Neurol. 2014;13(6):575–586. doi:10.1016/S1474-4422(14)70051-124703753
   PubMed Web of Science ®Google Scholar
• Gelpi E, Hoftberger R, Graus F, et al. Neuropathological criteria of anti-IgLON5-related tauopathy. Acta Neuropathol. 2016;132(4):531–543. doi:10.1007/s00401-016-1591-827358064
   PubMed Web of Science ®Google Scholar
• Wang P, Wing YK, Xing J, et al. Rapid eye movement sleep behavior disorder in patients with probable Alzheimer’s disease. Aging Clin Exp Res. 2016;28(5):951–957. doi:10.1007/s40520-015-0382-826022447
   PubMed Web of Science ®Google Scholar
• Cagnin A, Mariotto S, Fiorini M, et al. Microglial and neuronal TDP-43 pathology in Anti-IgLON5-related tauopathy. J Alzheimers Dis. 2017;59(1):13–20. doi:10.3233/JAD-17018928550263
   PubMed Web of Science ®Google Scholar
• Lo Coco D, Caruso G, Mattaliano A. REM sleep behavior disorder in patients with DJ-1 mutations and parkinsonism-dementia-ALS complex. Mov Disord. 2009;24(10):1555–1556. doi:10.1002/mds.2262919441133
   PubMed Web of Science ®Google Scholar
• Lo Coco D, Cupidi C, Mattaliano A, Baiamonte V, Realmuto S, Cannizzaro E. REM sleep behavior disorder in a patient with frontotemporal dementia. Neurol Sci. 2012;33(2):371–373. doi:10.1007/s10072-011-0702-521751100
   PubMed Web of Science ®Google Scholar
• Ebben MR, Shahbazi M, Lange DJ, Krieger AC. REM behavior disorder associated with familial amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2012;13(5):473–474. doi:10.3109/17482968.2012.67317222670878
   PubMed Web of Science ®Google Scholar
• Daoud H, Postuma RB, Bourassa CV, et al. C9orf72 repeat expansions in rapid eye movement sleep behaviour disorder. Can J Neurol Sci. 2014;41(6):759–762. doi:10.1017/cjn.2014.3925377888
   PubMed Web of Science ®Google Scholar
• Frauscher B, Iranzo A, Gaig C, et al. Normative EMG values during REM sleep for the diagnosis of REM sleep behavior disorder. Sleep. 2012;35(6):835–847. doi:10.5665/sleep.188622654203
   PubMed Web of Science ®Google Scholar
• Jung Y, St Louis EK. Treatment of REM sleep behavior disorder. Curr Treat Options Neurol. 2016;18(11):50. doi:10.1007/s11940-016-0433-227752878
   PubMed Web of Science ®Google Scholar
• Gunther R, Richter N, Sauerbier A, et al. Non-motor symptoms in patients suffering from motor neuron diseases. Front Neurol. 2016;7:117. doi:10.3389/fneur.2016.0011727504105
   PubMed Web of Science ®Google Scholar
• Baglioni C, Battagliese G, Feige B, et al. Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies. J Affect Disord. 2011;135(1–3):10–19. doi:10.1016/j.jad.2011.01.01121300408
   PubMed Web of Science ®Google Scholar
• Skapinakis P, Rai D, Anagnostopoulos F, Harrison S, Araya R, Lewis G. Sleep disturbances and depressive symptoms: an investigation of their longitudinal association in a representative sample of the UK general population. Psychol Med. 2013;43(2):329–339. doi:10.1017/S003329171200105522640482
   PubMed Web of Science ®Google Scholar
• Borasio GD, Voltz R. Palliative care in amyotrophic lateral sclerosis. J Neurol. 1997;244(Suppl 4):S11–S17.9402548
   PubMed Web of Science ®Google Scholar
• Neudert C, Oliver D, Wasner M, Borasio GD. The course of the terminal phase in patients with amyotrophic lateral sclerosis. J Neurol. 2001;248(7):612–616.11518004
   PubMed Web of Science ®Google Scholar
• Kettemann D, Funke A, Maier A, et al. Clinical characteristics and course of dying in patients with amyotrophic lateral sclerosis withdrawing from long-term ventilation. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18(1–2):53–59. doi:10.1080/21678421.2016.121473427534566
   PubMed Web of Science ®Google Scholar
• Takekawa H, Kubo J, Miyamoto T, Miyamoto M, Hirata K. Amyotrophic lateral sclerosis associated with insomnia and the aggravation of sleep-disordered breathing. Psychiatry Clin Neurosci. 2001;55(3):263–264. doi:10.1046/j.1440-1819.2001.00852.x11422868
   PubMed Web of Science ®Google Scholar
• Verschueren A, Kianimehr G, Belingher C, et al. Wish to die and reasons for living among patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2018.
   Google Scholar